Quality of life and chronic heart failure therapy guided by natriuretic peptides

American Heart Journal

Volumn 164, Issue 5, 2012, Pages

  Bhardwaj, Anju ^a   Rehman, Shafiq U ^a   Mohammed, Asim A ^a   Gaggin, Hanna K ^a   Barajas, Linda ^a   Barajas, Justine ^a   Moore, Stephanie A ^a   Sullivan, Dorothy ^a   Januzzi, James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEATH; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HF QUESTIONNAIRE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 84868607593     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.08.015     Document Type: Article

References (26)

1. D. Lloyd-Jones, R.J. Adams, and T.M. Brown Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 2010 e46 215
2. W.H. Barker, J.P. Mullooly, and W. Getchell Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994 Circulation 113 2006 799 805
3. F.D.R. Hobbs, J.E. Kenkre, and A.K. Roalfe Impact of heart failure and left ventricular systolic dysfunction on quality of life Eur Heart J 23 2002 1867 1876
4. E.F. Lewis, P.A. Johnson, and W. Johnson Preferences for quality of life or survival expressed by patients with heart failure J Heart Lung Transplant 20 2001 1016 1024
5. E.J. Stanek, M.B. Oates, and W.F. McGhan Preferences for treatment outcomes in patients with heart failure: symptoms versus survival J Card Fail 6 2000 225 232
6. H.M. Krumholz, D.W. Baker, and C.M. Ashton Evaluating quality of care for patients with heart failure Circulation 101 2000 122 140
7. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for heart and lung transplantation J Am Coll Cardiol 53 2009 e1 90
8. G. Majani, A. Giardini, and C. Opasich Effect of Valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial J Card Fail 11 2005 253 259
9. W.J. Rogers, D.E. Johnstone, and S. Yusuf Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. The SOLVD investigators J Am Coll Cardiol 23 1994 393 400
10. A. Hjalmarson, S. Goldstein, and B. Fagerberg Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 2000 1295 1302
11. P. Lechat, M. Packer, and S. Chalon Clinical effects of beta adrenergic blockade in chronic heart failure. A Meta-analysis of double-blind, placebo-controlled, randomized trials Circulation 98 1998 1184 1191
12. J.M. Brophy, L. Joseph, and J.L. Rouleau beta Blockers in congestive heart failure. A Bayesian meta-analysis Ann Intern Med 134 2001 550 560
13. D.K. Moser, I. Yarnokoski, and J.I. Sun Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure J Cardiac Fail 15 2009 763 769
14. K.B. Shah, W.J. Kop, and R.H. Christenson Post-discharge changes in NT-proBNP and quality of life after acute dyspnea hospitalization as predictors of one-year outcomes Clin Biochem 43 2010 1405 1410
15. J.L. Januzzi Jr., C.A. Camargo, and S. Anwaruddin The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
16. S. Masson, R. Latini, and I.S. Anand Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
17. J.L. Januzzi Jr., S.U. Rehman, and A.A. Mohammed Use of amino-terminal pro-B type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
18. T.S. Rector, S.H. Kubo, and J.N. Cohn Patient's self-assessment of their congestive heart failure: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire Heart Fail 3 1987 198 209
19. A. Bhardwaj, S.U. Rehman, and A. Mohammed Design and methods of the Pro-B type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study Am Heart J 159 2010 532 538
20. S. Masson, R. Latini, and I.S. Anand Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data Clin Chem 52 2006 1528 1538
21. J.G. Cleland, J.J. McMurray, and J. Kjekshus Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) J Am Coll Cardiol 54 2009 1850 1859
22. K. Morgan, H. McGee, and E. Shelley Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review Eur J Cardiovasc Prev Rehabil 14 2007 589 607
23. S.A. Luther, P.A. McCullough, and E.P. Havranek The relationship between B-type natriuretic peptide and health status in patients with heart failure J Card Fail 11 2005 414 421
24. M. Pfisterer, P. Buser, and H. Rickli BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial JAMA 301 2009 383 392
25. R.W. Troughton, C.M. Frampton, and T.G. Yandle Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
26. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2009 53 60